Wpływ preparatu TFX na aktywność proliferacyjną limfocytów karpi w badaniach in vivo i in vitro

• Autorzy: Sopinska A. , Grochola A.

Warianty tytułu

EN

Influence of TFX on proliferative activity of carp lymphocytes in vivo and in vitro

• Języki publikacji: PL

Abstrakty

EN

The purpose of this experiment was to estimate the most effective doses of TFX, used in injection and in bath, for the stimulation of the activity of lymphocytes in common carp The study was performed on 9-month-old carps obtained after spring catches (in March). The fish were divided into 10 groups. Fish in groups I-IV were given TFX by intramuscular injection at doses of 20, 10, 0.5, and 0.2 mg/fish. Fish in groups VI-IX were bathed for 24, 48, and 96 hours in TFX at concentrations of 200, 100, 50, and 20 mg/l of water. Groups V and X were control. Blood samples were taken immediately after the administration of TFX in bath and after 2, 7, 14, and 28 days in groups I-IV and VIII-IX. The following parameters were determined: the number of leukocytes and lymphocytes in 1 μl of blood, the percentage of ANAE+ and E-rosette-forming cells, and the proliferative activity of lymphocyte cell cultures stimulated with Con A. Results: TFX at doses of 100, 200 mg/l of water and 10, 20 mg/fish administered by injection showed a suppressive effect on the parameters investigated. TFX at doses of 50, 20 mg/l of water and 0.5, 0.2 mg/fish caused an increase in the number of leukocytes and lymphocytes, a higher percentage of ANAE+ cells and rosette-forming cells, as well as a multiple increase in the proliferative activity of lymphocytes stimulated with Con A. The highest values were obtained after the administration of TFX in a 96-hour bath at a concentration of 50 mg/l of water.

Słowa kluczowe

PL

ryby; karpie; immunomodulacja; preparat TFX; podawanie domiesniowe; podawanie w kapieli; limfocyty; aktywnosc proliferacyjna; badania in vitro; badania in vivo

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2016
• Tom: 72
• Numer: 05
• Opis fizyczny: s.307-311,tab.,bibliogr.

Twórcy

autor

Sopinska A.

• Zakład Chorób Ryb i Biologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Akademicka 12, 20-033 Lublin

autor

Grochola A.

• Zakład Chorób Ryb i Biologii, Wydział Medycyny Weterynaryjnej, Uniwersytet Przyrodniczy w Lublinie, ul.Akademicka 12, 20-033 Lublin

Bibliografia

• Bepler G.: Thymosin alpha-1 as adjunct for conventional therapy of malignant tumors: a review. Cancer Invest. 1994, 12, 491-496.
• Cillari E., Milano S., Perego R., Gromo G., D’Agostino R., Arcoleo F., Dieli M.: Modulation of IL-2, IFN-gamma, TNF-alpha and IL-4 production in mice of different ages by thymopentin. Int. J. Immunopharmacol. 1992, 14, 1029-1035.
• Čolić M., Popović R., Mrdaković D., Radeta M., Novaković J., Pavlović B., Vučević D.: Evaluation of the Immunomodulatory Properties of a Calf Lipid Thymus Extract and Standardization of a Method for Quantification of its Biological Activity. Am. J. Immunol. 2008, 3, 35-44.
• Čolić M., Vučević D., Kilibarda V., Radičević N., Savić M.: Modulatory effects of garlic extracts on proliferation of T-lymphocytes in vitro stimulated with concanavalin A. Phytomed. 2002, 9, 117-124.
• Cordero O. J., Pineiro A., Nogueira M.: Thymic peptides and preparations: an update. Arch. Immunol. Ther. Exp. 1999, 47, 77-82.
• Dardenne M., Savino W.: Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today 1994, 15, 518-523.
• Dąbrowski M. P., Dąbrowska-Bernstein B. K., Brzosko W. J.: Teoretyczne i praktyczne przesłanki substytujące funkcje grasicy. Pol. Tyg. Lek. 1983, 13, 385-387.
• Frasca D., Adorini L., Mancini C., Doria G.: Reconstitution of T cell functions in aging mice by thymosin alpha 1. Immunopharmacol. 1986, 11, 155-163.
• Garaci E., Pica F., Rasi G., Favalli C.: Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int. J. Immunopharmacol. 2000, 22, 1067-1076.
• Giełdanowski J.: Immunostymulacja farmakologiczna i jej znaczenie w badaniach podstawowych i lecznictwie, [w:] Immunoterapia. Wszechnica Polskiej Akademii Nauk, Wrocław 1984.
• Grinblat J., Schauenstein K., Saltz E., Trainin N., Globerson A.: Regulatory effects of thymus humoral factor on T cell growth factor in aging mice. Mech. Ageing. Dev. 1983, 22, 209-218.
• Hesser E. F.: Methods for Routine Fish Hematology. The Prog. Fish. Cult. 1960, 22, 164-171.
• Jabłonowska E., Tchórzewski H., Banasik M., Kuydowicz J.: The effect of Roferon A and TFX on the selected subpopulations of the peripheral blood lymphocytes in patients with chronic hepatitis C. Centr. Eur. J. Immunol. 2007, 32, 119-123.
• Kouttab N. M., Goldstein A. L., Lu M., Lu L., Campbell B., Maizel A. L.: Production of human B and T cell growth factors is enhanced by thymic hormones. Immunopharmacol. 1988, 16, 97-105.
• Krakowski L., Krzyżanowski J., Wrona Z., Kostro K., Siwicki A. K.: The influence of nonspecific immunostimulation of pregnant sows on the immunological value of colostrum. Vet. Immunol. Immunopathol. 2002, 87, 89-95.
• Marciniak A., Szpringer E., Lutnicki K., Bełtowski J.: Influence of thymus extract (TFX) on lipid peroxidation in the plasma of rats following thermal injury. Bull. Vet. Instit. Pulawy 2003, 47, 231-238.
• Meroni P. L., Barcellini W., Frasca D., Sguotti C., Borghi M. O., De Bartolo G., Doria G., Zanussi C.: In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin. Immunol. Immunopathol. 1987, 42, 151-159.
• Mueller J., Brun del Re G., Buerki H., Keller H. U., Hess M. W., Cottier H.: Nonspecific acid esterase activity: a criterion for differentiation of T and B lymphocytes in mouse lymph nodes. Eur. J. Immunol. 1975, 5, 270-274.
• Obmińska-Domoradzka B., Szczypka M., Debowy J.: Effects of thymomimetic drugs and zinc supplementation on the cellular immune response in hydrocortisone-suppressed mice. J. Vet. Med. 2002, 49, 469-475.
• Ossowicka-Stępińska J., Engel-Pietrzak K., Ronin-Walknowska E.: Therapeutic application of TFX and Ubiquitin complex in pregnant rabbits with antiphospholipid syndrome. Int. J. Thymol. 1999, 7, 596-600.
• Piekarska J.: Influence of selected immunotrophic compounds on T (CD4+, CD8+) and B-lymphocytes during the course of experimental trichinellosis in mice. Med. Weter. 2003, 59, 339-343.
• Sopińska A.: Odpowiedź immunologiczna limfocytów karpi na podstawie antygenu glikopeptydowego erytrocytów owcy. Med. Weter. 1986, 42, 230-232.
• Sopińska A., Guz L.: Immunostymulujące działanie lewamizolu i preparatu TFX-Polfa u karpi w warunkach eksperymentalnych. Med. Weter. 1993, 49, 547-550.
• Stasiak-Barmuta A., Puchnarewicz A., Piotrowska T., Hofman J.: Nonatopic bronchial asthma with pleuropneumonia treated with antiiflammatory and antiallergenic drugs concomitantly with immunoreconstructive therapy of TFX. Pediatria Polska 1998, 73, 961-964.
• Stosik M., Deptuła W.: Immunologia ryb. Wydawnictwo Naukowe Uniwersytetu Szczecińskiego, Szczecin 2001.
• Tarang S., Sodhi A.: Expression of Toll-like Receptors (TLRs) and Nucleotidebinding Oligomerization Domain (NODs) in murine peritoneal macrophages on in vitro treatment with Thymosin α 1. Am. J. Immunol. 2007, 3, 15-24.
• Tzehoval E., Sztein M. B., Goldstein A. L.: Thymosins alpha 1 and beta 4 potentiate the antigen-presenting capacity of macrophages. Immunopharmacol. 1989, 18, 107-113.
• Umiel T., Pecht M., Trainin N.: THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice. J. Biol. Response Mod. 1984, 3, 423-434.
• Zatz M. M., Goldstein A. L.: Mechanism of action of thymosin.I. Thymosin fraction 5 increases lymphokine production by mature murine T cells responding in a mixed lymphocyte reaction. J. Immunol. 1985, 134, 1032-1038.
• Zimecki M., Artym J., Kocięba M., Kuryszko J., Kaleta-Kuratewicz K., Marycz K.: Calf thymus extract attenuates severity of experimental encephalomyelitis in Lewis rats. Folia Neuropathol. 2010, 48, 246-257.